Expression and Purification of the Spike Protein (S) of Covid19 Virus for Diagnostic Purposes and Production of Live Attenuated Viral Vaccines Dr. Christopher Richardson Dalhousie University, IWK Health Total Project Value: $25,000 Funding Partners: Nova Scotia Health Research Coalition, Nova Scotia Health, Dalhousie University, Dalhousie Medical Research Foundation (DMRF), QEII Health Sciences Centre Foundation, IWK Foundation, IWK Health Centre, Dartmouth General Hospital Foundation (DGHF) Key Words: COVID-19, spike protein, immune diagnostic, discovery sciences, vaccine

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2021
  • Funder

    Research Nova Scotia
  • Principal Investigator

    Dr. Christopher Richardson
  • Research Location

    N/A
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

COVID-19, spike protein, immune diagnostic, discovery sciences, vaccine